Pilot Award for Diseases of the Pancreas supports UCSF investigators’ clinical and basic pilot research on pancreatic cancer-related diseases to improve early detection, diagnosis, treatment, and prevention.
Funder: University of California San Francisco
Due Dates (Anticipated): March 2027 (Application deadline)
Funding Amounts: Up to $50,000 in direct costs for one year; nonrenewable
Summary: Supports innovative UCSF pilot research on pancreatic cancer-related diseases, emphasizing early detection, diagnosis, treatment, and prevention.
Key Information: Residents, fellows, postdocs, and Specialists are not eligible; diabetes research unrelated to pancreatic cancer is excluded.
The Pilot Award for Diseases of the Pancreas supports UCSF investigators pursuing clinical or basic research directly related to pancreatic diseases associated with pancreatic cancer. Offered through UCSF’s Resource Allocation Program (RAP), the Pancreas Center funding emphasizes pancreatic ductal adenocarcinoma and projects addressing early detection and treatment. Research may focus on disease biology, early diagnosis, treatment, or prevention.
The program encourages innovative pilot projects that improve diagnosis and treatment and can lead to successful future NIH grant applications. Review considers scientific quality, significance to pancreatic disease research, and the quality and promise of the investigator and research team. Projects must be feasible within a one-year funding period.